ENTA EPS Estimates
Enanta Pharmaceuticals, Inc.
$11.18
-$0.34(-2.95%)
33
Overall
60
Value
10
Tech
31
Quality
Market Cap
$325.62M
Volume
227.61K
52W Range
$10.20 - $17.15
Target Price
$19.83
ENTA EPS estimates: the consensus estimate for Enanta Pharmaceuticals, Inc.'s current fiscal year is -$2.36 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ENTA EPS Estimates
- EPS estimate, current quarter
- $-0.82
- EPS estimate, next quarter
- $-0.58
- EPS estimate, current year
- $-2.36
- EPS estimate, next year
- $-2.50
- EPS growth, 3-year
- +13.39%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.84 |
| 2024 | $-5.48 |
| 2023 | $-6.38 |
| 2022 | $-5.91 |
| 2021 | $-3.92 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENTA | $11.18 | -3.0% | 227.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enanta Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW